TY - JOUR
T1 - Hexamerization
T2 - explaining the original sin of IgG-mediated complement activation in acute lung injury
AU - Kulkarni, Hrishikesh S.
AU - Milliken, John T.
N1 - Publisher Copyright:
Copyright: © 2024, Kulkarni et al.
PY - 2024/6/3
Y1 - 2024/6/3
N2 - Although antibody-mediated lung damage is a major factor in transfusion-related acute lung injury (ALI), autoimmune lung disease (for example, coatomer subunit α [COPA] syndrome), and primary graft dysfunction following lung transplantation, the mechanism by which antigen-antibody complexes activate complement to induce lung damage remains unclear. In this issue of the JCI, Cleary and colleagues utilized several approaches to demonstrate that IgG forms hexamers with MHC class I alloantibodies. This hexamerization served as a key pathophysiological mechanism in alloimmune lung injury models and was mediated through the classical pathway of complement activation. Additionally, the authors provided avenues for exploring therapeutics for this currently hard-to-treat clinical entity that has several etiologies but a potentially focused mechanism.
AB - Although antibody-mediated lung damage is a major factor in transfusion-related acute lung injury (ALI), autoimmune lung disease (for example, coatomer subunit α [COPA] syndrome), and primary graft dysfunction following lung transplantation, the mechanism by which antigen-antibody complexes activate complement to induce lung damage remains unclear. In this issue of the JCI, Cleary and colleagues utilized several approaches to demonstrate that IgG forms hexamers with MHC class I alloantibodies. This hexamerization served as a key pathophysiological mechanism in alloimmune lung injury models and was mediated through the classical pathway of complement activation. Additionally, the authors provided avenues for exploring therapeutics for this currently hard-to-treat clinical entity that has several etiologies but a potentially focused mechanism.
UR - http://www.scopus.com/inward/record.url?scp=85195014277&partnerID=8YFLogxK
U2 - 10.1172/JCI181137
DO - 10.1172/JCI181137
M3 - Review article
C2 - 38828725
AN - SCOPUS:85195014277
SN - 0021-9738
VL - 134
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 11
M1 - e181137
ER -